Surrey researchers Sign in
Back
Serum insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation status in subjects with and without ischaemic heart disease.
Journal article

Serum insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation status in subjects with and without ischaemic heart disease.

A Borai, C Livingstone, M Ghayour-Mobarhan, A Abuosa, S Shafi, S Mehta, A Heidari, A Emadzadeh, G Wark and G Ferns
Atherosclerosis, Vol.208(2), pp.593-598
02/2010
DOI: https://doi.org/10.1016/j.atherosclerosis.2009.08.010

Abstract

Adult Cardiovascular Diseases Enzyme-Linked Immunosorbent Assay Female Glucose Tolerance Test Humans Immunoassay Insulin-Like Growth Factor Binding Protein 1 Male Middle Aged Myocardial Ischemia Phosphorylation ROC Curve Risk Factors Serine
Insulin-like growth factor binding protein-1 (IGFBP-1) modulates the activity of IGF-I. It exists in serum as phosphorylated and less phosphorylated forms. We wished to measure serum levels of both these forms of IGFBP-1, using a novel assay, in subjects with, or without ischaemic heart disease (IHD).
url
http://www.ncbi.nlm.nih.gov/pubmed/19732896View
Author

Metrics

23 Record Views
13 Times Cited - Web of Science

Details

Usage Policy

Usage details for all content viewed and downloaded in this site are shared with IRUS-UK (Institutional Repository Usage Statistics UK). Cookies are used to remember your decision. Click Accept to accept usage details sharing and the cookies.

Learn more